Insurance had a good day.

Insurance had a good day. Regional banks did not. Let us get into it.

Travelers Companies opens the slate and it earned that spot. Eighty-three percent EPS growth year over year, the stock gaps nine point two percent, and the Street is just now remembering that when catastrophe losses normalize, this underwriting machine prints cash at a rate a ten-point-one forward multiple does not come close to capturing. The fifteen and a half percent net margin is the tell — that is not a lucky quarter, that is pricing discipline finally showing up in the combined ratio. And here is what it is hiding: they printed ten-oh-four against a five-forty-one estimate. That is not a beat. That is a different zip code. The Street did not miss by a rounding error — they missed by a thesis. Watch what gets revised in the next analyst cycle.

Now the regional bank pile. Citizens Financial, Fifth Third, Regions, and Truist all reported today, and they all gapped down. The throughline is obvious once you see it: every one of these names is posting revenue growth in the forty-five to sixty-two percent range year over year, but the market does not care about the top line right now. It cares about what net interest margin compression and credit normalization do to the bottom line from here.

Citizens Financial is the one I want to flag specifically. Sixty-two point seven percent revenue growth and thirty-two percent EPS growth, and the stock falls two point seven percent. That divergence tells you the Street is either discounting the revenue quality or pricing in a NIM rollover that the headline number does not show yet. I will be in the footnotes on that one.

Fifth Third is the name that gets the knife today. EPS down five and a half percent year over year while revenue is up fifty-eight percent — that gap is almost entirely the story of funding costs outrunning asset repricing. When deposit betas catch up faster than loan yields reset, the income statement gets squeezed from both sides, and at a twenty-four-point-two multiple, Fifth Third is the most expensive name in this group to absorb that kind of margin erosion going forward.

Regions Financial is the quieter version of the same problem — fourteen percent EPS growth is respectable, but a twelve-point-four multiple says the market is already treating this as a show-me story on credit quality.

Truist Financial rounds out the bank cohort. Seventeen percent EPS growth, twelve-point-one multiple, down one point four percent on the print. Unremarkable on the surface, but Truist is still digesting its merger costs and the revenue synergy timeline is the variable nobody has priced cleanly.

Abbott Laboratories is the outlier in today's slate. EPS down sixty-one point two percent year over year sounds catastrophic until you remember that number is lapping the COVID testing windfall. The underlying device and diagnostics business at eight point one percent revenue growth is the actual story, and a thirty-two-point-three multiple says the Street is already looking through the comp. Whether that confidence is warranted is the question.

Coming up in full teardowns — Travelers Companies, because that combined ratio deserves a proper dissection, and Citizens Financial, because sixty-two percent revenue growth with a down print is exactly the kind of contradiction that lives in the segment disclosures.

That is the menu. The numbers were always there — most people just do not look. See you at the next filing.